Veracyte, Inc.

VCYT

$45.43

Name : Veracyte, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $3,652,150,784.00

EPSttm : 1.4

Veracyte, Inc.

$45.43

6.41%

$3.11

VCYT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

10.65

Margin Of Safety %

-13

Put/Call OI Ratio

0.65

EPS Next Q Diff

0.08

EPS Last/This Y

1.07

EPS This/Next Y

0.04

Price

45.42

Target Price

58.42

Analyst Recom

1.43

Performance Q

-24.9

Upside

-59.7%

Beta

1.95

Ticker: VCYT

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-31	VCYT	43.19	0.44	0.03	6012
2026-09-01	VCYT	43.43	0.41602708803612	0	6273
2026-09-02	VCYT	45.01	0.43	0.04	6098
2026-09-03	VCYT	44.64	0.43	2.32	6114
2026-09-04	VCYT	42.53	0.47	137.00	6305
2026-09-08	VCYT	42.38	0.47	2.79	6300
2026-09-09	VCYT	43.81	0.49	0.13	6359
2026-09-10	VCYT	42.02	0.48	8.52	6494
2026-09-11	VCYT	40.87	0.52	5.16	6676
2026-09-14	VCYT	41.19	0.57	4.00	6951
2026-09-15	VCYT	40.12	0.58	10.44	6968
2026-09-16	VCYT	38.49	0.63	7.67	7230
2026-09-17	VCYT	40.54	0.69	0.40	7494
2026-09-18	VCYT	39.61	0.68	10.93	7499
2026-09-21	VCYT	41.48	0.16	0.23	3568
2026-09-22	VCYT	43.38	0.16	0.27	3622
2026-09-23	VCYT	43.84	0.17	0.00	3655
2026-09-24	VCYT	48.56	0.17	3.72	3654
2026-09-25	VCYT	45.48	0.65	0.69	5683
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-31	VCYT	43.19	-19.1	-35.5	1.91
2026-09-01	VCYT	43.42	-19.1	-34.7	1.91
2026-09-02	VCYT	44.93	-19.1	-8.6	1.91
2026-09-03	VCYT	44.59	-19.1	-13.6	1.91
2026-09-04	VCYT	42.51	-19.1	-18.3	1.91
2026-09-08	VCYT	42.44	-19.1	-13.0	1.91
2026-09-09	VCYT	43.84	-19.1	-8.8	1.91
2026-09-10	VCYT	42.00	-19.1	-17.7	1.91
2026-09-11	VCYT	40.88	-19.1	-15.9	1.91
2026-09-14	VCYT	41.22	-19.1	-11.7	1.91
2026-09-15	VCYT	40.16	-18.6	-15.7	1.91
2026-09-16	VCYT	40.16	-18.6	-15.7	1.91
2026-09-17	VCYT	40.56	-18.6	-6.3	1.91
2026-09-18	VCYT	39.77	-18.6	-15.1	1.91
2026-09-21	VCYT	41.51	-18.6	-7.5	1.91
2026-09-22	VCYT	43.36	-19.3	-7.5	1.91
2026-09-23	VCYT	43.84	-19.3	-11.5	1.91
2026-09-24	VCYT	48.56	-19.3	0.0	1.91
2026-09-25	VCYT	45.42	-19.3	-20.2	1.91
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

18 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-31	VCYT	-16.16	0.53	8.61
2026-09-01	VCYT	-16.16	0.53	8.61
2026-09-02	VCYT	-16.16	0.53	8.61
2026-09-03	VCYT	-16.16	0.53	8.61
2026-09-04	VCYT	-16.24	0.53	8.61
2026-09-08	VCYT	-12.96	0.83	8.61
2026-09-09	VCYT	-12.96	0.83	8.61
2026-09-10	VCYT	-12.96	0.83	8.61
2026-09-11	VCYT	-12.96	0.83	10.24
2026-09-14	VCYT	-13.38	0.85	10.24
2026-09-15	VCYT	-13.38	0.85	10.24
2026-09-16	VCYT	-13.38	0.85	10.24
2026-09-17	VCYT	-13.64	0.85	10.24
2026-09-18	VCYT	-13.64	0.85	10.24
2026-09-21	VCYT	-13.64	0.53	10.23
2026-09-23	VCYT	-13.84	0.53	10.23
2026-09-24	VCYT	-13.84	0.53	10.23
2026-09-25	VCYT	-13.84	0.53	10.65
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

18 items 1 of 1

Last Quarter Act. EPS

0.37

Avg. EPS Est. Current Quarter

0.41

Avg. EPS Est. Next Quarter

0.45

Insider Transactions

-13.84

Institutional Transactions

0.53

Beta

1.95

Average Sales Estimate Current Quarter

147

Average Sales Estimate Next Quarter

157

Fair Value

39.5

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

25.4

Max Drawdown 5-Year %

-71.5

Target Price

58.42

P/E

32.23

Forward P/E

23.28

PEG

4.4

P/S

6.5

P/B

2.63

P/Free Cash Flow

EPS

1.41

Average EPS Est. Cur. Y

1.91

EPS Next Y. (Est.)

1.95

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.37

Relative Volume

1.22

Return on Equity vs Sector %

-18

Return on Equity vs Industry %

-3.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

-20.2

◆ VCYT Healthcare

$45.43

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

13/25

Volume

1/15

Valuation

15/20

TP/AR

4/10

Options

5/10

RSI

54.2

Range 1M

68.1%

Sup Dist

0.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

2/25

Growth

17/30

Estimates

6/20

Inst/Vol

6/15

Options

6/10

EPS Yr

7.5%

EPS NY

1.9%

52W%

51.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -20.3% upside

Quality

8/30

Valuation

3/30

Growth

11/25

Stability

9/10

LT Trend

2/5

Upside

-20.3%

Quality

MoS

-13%

VCYT — P/E HistoricalBiotechnology

Veracyte, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 755

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

VCYT

Latest News

—

Caricamento notizie per VCYT…

stock quote shares VCYT – Veracyte Inc. Stock Price stock today

news today VCYT – Veracyte Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VCYT – Veracyte Inc. yahoo finance google finance

stock history VCYT – Veracyte Inc. invest stock market

stock prices VCYT premarket after hours

ticker VCYT fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VCYT

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y